Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Anderson, SC
NPI: 1427275437Primary Practice Location
ANMED HEALTH
800 N Fant St, Anderson, SC
Primary Employer
Anderson Area Cancer Center
aaccsc.com
HQ Phone
Get M.D. Jay's Phone Numberphone_androidMobile
Get M.D. Jay's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
SC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 314 | 1,356 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 250 | 645 |
| 3 | 80053Blood test, comprehensive group of blood chemicals | 240 | 1,062 |
| 4 | 82728Ferritin (blood protein) level | 131 | 336 |
| 5 | 83550Iron binding capacity | 128 | 327 |
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib.
Authors: Augustine, Titto, Maitra, Radhashree, Zhang, Jinghang, Nayak, Jay, Goel, Sanjay
Journal: Invest New Drugs
Publication Date: 2019-01-05
Authors: Nayak, Jay, Goel, Sanjay
Journal: Clin Colorectal Cancer
Publication Date: 2011-05-01
Acral metastases from laryngeal carcinoma.
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, DRUG: Capecitabine, DRUG: Etoposide
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Capecitabine, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Leucovorin, OTHER: Patient Observation, DRUG: Leucovorin Calcium
